NCT01944631View on ClinicalTrials.gov

Iota-Carrageenan Nasal Spray in Common Cold

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Common Cold
Interventions
DEVICE

Placebo

Nasal spray saline

DEVICE

Iota-Carrageenan

Nasal spray containing 1.20 g/l Iota-Carrageenan in saline

Trial Locations (1)

Unknown

1326.1.44001 Boehringer Ingelheim Investigational Site, Cardiff

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01944631 - Iota-Carrageenan Nasal Spray in Common Cold | Biotech Hunter | Biotech Hunter